Primary Job Title President and Chief Executive Officer, Director and Co-founder Primary Organization 
Thrombolytic Science International
Location Cambridge, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
Facebook View on Facebook LinkedIn View on LinkedIn
Alexis Wallace has over 20 years of international business development and operational experience, including more than two decades with leading biopharmaceutical companies and ventures. Prior to joining TSI, Mr. Wallace was Executive Director of Medicine in Need, a not-for-profit biotechnology company funded by the Bill and Melinda Gates
Foundation. There, Mr. Wallace oversaw the development of an inhaled version of an anti-tuberculosis drug from pre-IND through phase I human clinical trials. Mr. Wallace was also a Principal in the Business Development arm of Puretech Ventures, where he created and grew the company’s European business. Mr. Wallace also served as the Director of Science Strategy at Genzyme Corporation, where he was instrumental in the establishment of major joint ventures resulting in three commercialized products. Mr. Wallace holds an undergraduate degree in Life Sciences from Université Pierre et Marie Curie, Paris, France; an MScEng in Organic Chemistry from École Supérieure de Chimie Industrielle de Lyon, France; and an MBA from the Tuck Business School at Dartmouth College. Mr. Wallace is a member of the Board of Directors of the Vascular Laboratory, Inc.
